These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 1381766

  • 1. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
    Moe GW, Canepa-Anson R, Armstrong PW.
    J Cardiovasc Pharmacol; 1992 May; 19(5):691-700. PubMed ID: 1381766
    [Abstract] [Full Text] [Related]

  • 2. Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension.
    Cusson JR, Hamet P, Gutkowska J, Kuchel O, Genest J, Cantin M, Larochelle P.
    J Hypertens; 1987 Aug; 5(4):435-43. PubMed ID: 2822796
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics, hemodynamic, renal, and neurohormonal effects of atrial natriuretic factor in experimental heart failure.
    Moe GW, Forster C, de Bold AJ, Armstrong PW.
    Clin Invest Med; 1990 Jun; 13(3):111-8. PubMed ID: 2142031
    [Abstract] [Full Text] [Related]

  • 4. [Hemodynamic and renal effects of synthetic atrial natriuretic factor (alpha-h-ANF) in patients with congestive heart failure].
    Fontana F, Guardigli G, Cappelli M, Bernardi P.
    G Ital Cardiol; 1988 Jul; 18(7):567-77. PubMed ID: 2976692
    [Abstract] [Full Text] [Related]

  • 5. Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure.
    Volpe M, Tritto C, De Luca N, Mele AF, Lembo G, Rubattu S, Romano M, De Campora P, Enea I, Ricciardelli B.
    J Clin Invest; 1991 Nov; 88(5):1481-9. PubMed ID: 1834698
    [Abstract] [Full Text] [Related]

  • 6. [Atrial natriuretic factor, catecholamines and the renin-angiotensin system in cardiac insufficiency. Relation to hemodynamic parameters].
    Komajda M, Carayon A, Nguyen JP, Maistre G, Drobinski G, Legrand S, Landault C, Legrand JC, Grosgogeat Y.
    Arch Mal Coeur Vaiss; 1988 Jul; 81(7):845-53. PubMed ID: 2973293
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular, renal and endocrine responses to low doses of atrial natriuretic factor in mild essential hypertension.
    Cusson JR, Thibault G, Kuchel O, Hamet P, Cantin M, Larochelle P.
    J Hum Hypertens; 1989 Apr; 3(2):89-96. PubMed ID: 2547952
    [Abstract] [Full Text] [Related]

  • 8. [Effects of naloxone on plasma levels of atrial natriuretic factor and noradrenaline during water load in moderate heart failure].
    Tarsi G, Paradossi U, Tartuferi L, Schipani A, Palmisano D, De Iasio R, Carboni L, Fontana F, Bernardi P.
    G Ital Cardiol; 1996 Aug; 26(8):879-85. PubMed ID: 9005170
    [Abstract] [Full Text] [Related]

  • 9. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
    Richards AM, Crozier IG, Espiner EA, Ikram H, Yandle TG, Kosoglou T, Rallings M, Frampton C.
    J Cardiovasc Pharmacol; 1992 Aug; 20(5):735-41. PubMed ID: 1280735
    [Abstract] [Full Text] [Related]

  • 10. Losartan improves the natriuretic response to ANF in rats with high-output heart failure.
    Abassi ZA, Kelly G, Golomb E, Klein H, Keiser HR.
    J Pharmacol Exp Ther; 1994 Jan; 268(1):224-30. PubMed ID: 8301562
    [Abstract] [Full Text] [Related]

  • 11. Renal effects of brain natriuretic peptide in patients with congestive heart failure.
    Jensen KT, Eiskjaer H, Carstens J, Pedersen EB.
    Clin Sci (Lond); 1999 Jan; 96(1):5-15. PubMed ID: 9857101
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G, Lazzeri C, Pascale A, Sestini S, Bisi G, Sciagrà R, Vecchiarino S, Raggi VC, Barletta G, Laffi G, Gentilini P.
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [Abstract] [Full Text] [Related]

  • 13. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.
    Cody RJ, Atlas SA, Laragh JH, Kubo SH, Covit AB, Ryman KS, Shaknovich A, Pondolfino K, Clark M, Camargo MJ.
    J Clin Invest; 1986 Nov; 78(5):1362-74. PubMed ID: 2945832
    [Abstract] [Full Text] [Related]

  • 14. Effects of clonidine and dihydralazine on plasma ANF and cyclic GMP levels in humans during volume loading.
    Müller T, Heim JM, Weil J, Wehling M, Witzgall H, Gerzer R.
    J Cardiovasc Pharmacol; 1987 Nov; 10 Suppl 12():S163-6. PubMed ID: 2455172
    [Abstract] [Full Text] [Related]

  • 15. Physiological effects of synthetic atrial natriuretic factor in normal conscious dogs.
    Moe GW, Forster C, de Bold AJ, Armstrong PW.
    Clin Invest Med; 1988 Dec; 11(6):417-24. PubMed ID: 2976333
    [Abstract] [Full Text] [Related]

  • 16. [Effects of phenylephrine on atrial natriuretic factor and the renin-aldosterone axis in normal patients and essential hypertensive patients].
    Closas J, Genest J, Larochelle P, Cusson J, Gutkowska J, Hamet P, De Léan A, Thibault G, Cantin M.
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():75-8. PubMed ID: 2847676
    [Abstract] [Full Text] [Related]

  • 17. [Renal resistance to atrial natriuretic factor as a cause of the escape failure phenomenon in patients with non-ascitic liver cirrhosis].
    Tesar V, Spicák J, Horký K, Zabka J, Widimský J, Jedlicka J, Marecek Z.
    Cas Lek Cesk; 1994 Feb 14; 133(4):111-5. PubMed ID: 8137382
    [Abstract] [Full Text] [Related]

  • 18. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man.
    Holmes SJ, Espiner EA, Richards AM, Yandle TG, Frampton C.
    J Clin Endocrinol Metab; 1993 Jan 14; 76(1):91-6. PubMed ID: 8380606
    [Abstract] [Full Text] [Related]

  • 19. Dissociation of hemodynamic and renal effects of i.v. alpha-hANF (99-126) in conscious calves.
    Windberger U, Vierhapper H, Osterode W, Nowotny P, Losert U.
    Horm Metab Res; 1993 May 14; 25(5):259-63. PubMed ID: 8330860
    [Abstract] [Full Text] [Related]

  • 20. Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites.
    Dussaule JC, Grangé JD, Wolf JP, Lecomte JM, Gros C, Schwartz JC, Bodin F, Ardaillou R.
    J Clin Endocrinol Metab; 1991 Mar 14; 72(3):653-9. PubMed ID: 1847706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.